InnovAge (INNV) Stock: Buy, Sell, or Hold?

INNV - InnovAge Holding Corp. Common Stock

SERVICES-HEALTH SERVICES
$8.80
0.00 (0.00%) ▲
5d: -0.45%
30d: -18.74%
90d: -26.61%
HOLD
MODERATE Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 03, 2026

Get Alerted When INNV Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: INNV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$24.34
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$15.11
41.8% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: INNV is currently trading at $8.80, which is considered oversold relative to its 30-day fair value range of $10.04 to $11.22. From a valuation perspective, the stock is trading at a discount (Forward PE: 17.6) compared to its historical average (26.3). Remarkably, the market is currently pricing in an annual earnings decline of 12.6% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, INNV is in a strong uptrend. Immediate support is located at $8.40, while resistance sits at $10.95.

Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.00 (+36.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $10.04 - $11.22
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 79.5%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 36.4% below Wall St target ($12.00)
  • NEUTRAL: Bottoming setup forming (45/100) — watch for confirmation

Trading Range Analysis

30-Day Trading Range $10.04 - $11.22
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $8.40
Resistance Level $10.95
Current Trend Strong Uptrend
Technical data as of Oct 1, 2026

Fundamental Context

Forward P/E (Next Year Est.) 17.60
Wall Street Target $12.00 (+36.4%)
Revenue Growth (YoY) 18.3%
Earnings Growth (YoY) -87.8%
Profit Margin -0.3%
Valuation Discount vs History -12.6% cheaper
PE vs Historical 17.6 vs 26.3 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -12.6% (market-implied from PE analysis)
1-Year Target $7.92 (-10%)
2-Year Target $7.13 (-19%)
3-Year Target $6.42 (-27%)
3-Yr Target (if PE normalizes) (PE: 18→26) $9.59 (+9%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 20.4, Growth: 38.9%) $27.33 (+211%)
Base: (SPY PE: 17.6, Growth: 38.9%) $23.58 (+168%)
Bear: (PE: 15.0, Growth: 38.9%) $20.04 (+128%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.6 to 26.3
Stabilization Target: $13.15 (+49.4%)
PE Expansion Potential: +49.4%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 02, 2026 6:09 AM ET
Data refreshes hourly during market hours. Next update: 7:09 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for INNV.

Create Free Account

Already have an account? Log In

Top Rated Medical Care Facilities Stocks

Top-rated stocks in Medical Care Facilities by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
THC
Tenet Healthcare Corpora…
STRONG BUY
22 analysts
$285 58 HOLD
HCA
HCA Healthcare, Inc.
BUY
25 analysts
$454 46 HOLD
EHC
Encompass Health Corp
STRONG BUY
12 analysts
$148 54 HOLD
CMPS
Compass Pathways Plc
STRONG BUY
11 analysts
$24 45 HOLD
ADUS
Addus HomeCare Corporati…
STRONG BUY
11 analysts
$134 53 HOLD

More Analysis for INNV

INNV Technical Chart INNV Price Prediction INNV Earnings Date INNV Investment Advisor INNV Fair Price Analyzer INNV Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals